Ultragenyx unit Amlogenyx presents at Wells Fargo Healthcare Conference Sept. 8 - RARE News | RalliesUltragenyx unit Amlogenyx presents at Wells Fargo Healthcare Conference Sept. 8
R
RARE• Amlogenyx to present at Wells Fargo Healthcare Conference
- Ultragenyx subsidiary Amlogenyx will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Sept. 8, 2026.
- Management presentation scheduled for 3:00 p.m. ET.
- Amlogenyx is developing AM805, a clinic-ready gene therapy designed to reduce amyloid (Aβ42) accumulation in Alzheimer’s disease.
- The unit is raising a Series A financing to support Phase 2a clinical proof of concept.
•
